| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/02/2009 | WO2009023269A3 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-b[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases |
| 04/02/2009 | WO2006101783A3 Compounds and compositions as protein kinase inhibitors |
| 04/02/2009 | WO2006063133A3 Biomarker for inflammatory bowel disease |
| 04/02/2009 | US20090088571 Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides |
| 04/02/2009 | US20090088569 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation, and their use as pharmaceutical compositions |
| 04/02/2009 | US20090088568 Vinorelbine derivatives |
| 04/02/2009 | US20090088446 Purinone derivatives as hm74a agonists |
| 04/02/2009 | US20090088445 Deazapurines useful as inhibitors of Janus kinases |
| 04/02/2009 | US20090088437 nicotinic receptor agonists such as 3-{[(1S,4S)-5-Methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]carbonyl}-1,2-benzisothiazole, used for the treatment of brain disorders |
| 04/02/2009 | US20090088418 4-substituted quinuclidine derivatives, methods of production, and pharmaceutical uses thereof |
| 04/02/2009 | US20090088407 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 04/02/2009 | US20090087462 Use of pyrimidine derivatives for cosmetic purposes |
| 04/02/2009 | US20090084286 Diketopyrrolopyrrole Pigments Having Heightened Fastnesses and Processes for Preparing Them |
| 04/02/2009 | CA2700979A1 Pyrimidine derivatives as protein kinase inhibitors |
| 04/02/2009 | CA2700936A1 Production method for pyrazol-3-yl-benzamide derivative |
| 04/02/2009 | CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | CA2700295A1 Polo-like kinase inhibitors |
| 04/02/2009 | CA2699607A1 Polo-like kinase inhibitors |
| 04/02/2009 | CA2695193A1 Process for the synthesis of e1 activating enzyme inhibitors |
| 04/01/2009 | EP2042504A1 Fused azole-pyrimidine derivatives |
| 04/01/2009 | EP2042502A1 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
| 04/01/2009 | EP2041138A2 Pyrrolotriazine kinase inhibitors |
| 04/01/2009 | EP2041137A2 Pyrrolopyrimidines for pharmaceutical compositions |
| 04/01/2009 | EP2041132A2 New compounds |
| 04/01/2009 | EP2041131A1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
| 04/01/2009 | EP2040564A1 Zilpaterol enantiomer compositions and methods of making and using such compositions |
| 04/01/2009 | EP1594869B9 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 04/01/2009 | CN101400681A Substituted indazole derivatives, their manufacture and use as pharmaceutical agents |
| 04/01/2009 | CN101400678A Thiophene-carboxamides useful as inhibitors of protein kinases |
| 04/01/2009 | CN101400407A Tropane prodrugs with central nervous system activity |
| 04/01/2009 | CN101397300A Dipeptidase-IV inhibitor derivates |
| 04/01/2009 | CN101397299A Method for synthesizing pyrazole[3,4-d] pyrimidinone |
| 04/01/2009 | CN100473654C S type 4-substituted hydroxypyranoindolidine compound and derivatives and preparation thereof |
| 04/01/2009 | CN100473653C Near infrared meso-position nitrogen and sulfur substituted hepta-methyl-cyanine fluorochrome for bioanalysis |
| 04/01/2009 | CN100473609C Synthetic porous crystalline MCM-68, and synthesis and use thereof |
| 03/31/2009 | US7511153 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof |
| 03/31/2009 | US7511145 Bicyclic heteroaryl derivatives |
| 03/31/2009 | US7511138 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 03/31/2009 | US7511068 antiinflammatory agents |
| 03/31/2009 | US7511065 Mixed lineage kinase modulators |
| 03/31/2009 | US7511050 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders |
| 03/31/2009 | US7511049 7-carboxamido- or sulfonamido-substituted: 2-Phenyl-3-cyclopropyl-7-(4-pyridylcarboxamido)pyrazolo[1.5a]pyrimidine; anticarcinogenic, antiinflammatory, neurodegenerative agent, viricide; breast canceer, arthritis, Alzheimer's disease, cardiovascular diseases, with other active compounds |
| 03/31/2009 | US7511048 Hyperproliferative disorders; packages |
| 03/31/2009 | US7511041 Fused azole-pyrimidine derivatives |
| 03/31/2009 | US7511032 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| 03/31/2009 | US7510739 Assembled hematin, method for forming same and method for polymerizing aromatic monomers using same |
| 03/31/2009 | US7510702 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2418762C Meso-meso, .beta.-.beta., .beta.-.beta. triply linked porphyrins and its discrete oligomeric arrays and synthetic methods thereof |
| 03/26/2009 | WO2009039387A1 Pyrazolo[5, 1-c] [1,2,4] triazines, methods for preparation and use thereof |
| 03/26/2009 | WO2009038974A1 Compounds and compositions as modulators of gpr119 activity |
| 03/26/2009 | WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/26/2009 | WO2009038021A1 4-sulfonylpiperidine derivatives |
| 03/26/2009 | WO2009038012A1 Heterocyclic compound |
| 03/26/2009 | WO2009037642A1 Heterocyclic scaffolds useful for preparation of combinatorial libraries, libraries and methods of preparation thereof |
| 03/26/2009 | WO2009037556A1 New agents for the treatment of the low urinary tract dysfunctions |
| 03/26/2009 | WO2009037467A1 Pyrrolopyrimidine compounds |
| 03/26/2009 | WO2009037394A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/26/2009 | WO2009037357A1 Benzimidazole nf- kappab inhibitors |
| 03/26/2009 | WO2009037229A1 Process for the manufacture of bridged monobactam intermediates |
| 03/26/2009 | WO2009016460A3 Pyrazole compounds and their use as raf inhibitors |
| 03/26/2009 | WO2009006389A8 Pyrimidine derivatives useful as raf kinase inhibitors |
| 03/26/2009 | WO2008106058A3 Inhibitors of serine proteases |
| 03/26/2009 | WO2005084295A3 Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3 |
| 03/26/2009 | US20090082566 Di- and tri-peptide mono- and di-esters of acyclovir and gancyclovir and derivatives; esters have sufficient hydrophilicity to be formulated into pharmacologically active compositions such as aqueous solutions, eye drops; treating herpes simplex types 1, 2, varicella zoster virus, human cytomegalovirus |
| 03/26/2009 | US20090082564 Ink jet dye design |
| 03/26/2009 | US20090082559 Process for Crystallization of Benazepril Hydrochloride |
| 03/26/2009 | US20090082387 Deuterium-enriched nvp-bez234 |
| 03/26/2009 | US20090082374 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 03/26/2009 | US20090082370 Pharmaceutical Combinations of PK Inhibitors and Other Active Agents |
| 03/26/2009 | US20090082369 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 03/26/2009 | US20090082368 Methods of modulating neurotrophin-mediated activity |
| 03/26/2009 | US20090082354 Pyrazolo[5, 1-c] [1,2,4] triazines, methods for preparation and use thereof |
| 03/26/2009 | US20090082346 Substituted Pyrrolo-Pyrazole Derivatives as Kinase Inhibitors |
| 03/26/2009 | US20090081165 Bicyclic heteroaryl derivatives |
| 03/26/2009 | US20090081145 Process for forming disulphide bridges |
| 03/26/2009 | US20090081129 Bioluminescent Endoscopy Methods And Compounds |
| 03/26/2009 | CA2700327A1 Pyrazolo[5, 1-c] [1,2,4] triazines, methods for preparation and use thereof |
| 03/26/2009 | CA2699817A1 Benzimidazole nf- kappab inhibitors |
| 03/26/2009 | CA2699275A1 4-sulfonylpiperidine derivative |
| 03/26/2009 | CA2697551A1 Piperidine derivatives as modulators of gpr119 activity |
| 03/26/2009 | CA2693116A1 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/25/2009 | EP2039695A1 Bicyclic heterocyclic compound and use thereof |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/25/2009 | EP2039683A2 Vasculostatic agents and methods of use thereof |
| 03/25/2009 | EP2038286A1 Pyrro[1,2-b]pyridazinone compounds |
| 03/25/2009 | EP2038285A2 Adenosine a2a receptor antagonists |
| 03/25/2009 | EP2038284A2 Heterobicylic metalloprotease inhibitors |
| 03/25/2009 | EP2038283A2 Heterobicyclic metalloprotease inhibitors |
| 03/25/2009 | EP2038282A1 Salts of pyrrolopyrimidinone derivatives and process for preparing the same |
| 03/25/2009 | EP2038272A2 Pyridinonyl pdk1 inhibitors |
| 03/25/2009 | EP2038263A1 Novel aromatic aza heterocycles, method of production and use of the material in organic electronics |
| 03/25/2009 | EP2037922A2 Prolyl hydroxylase inhibitors |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1718624B1 Benzamide derivatives and their use as glucokinase activating agents |
| 03/25/2009 | EP1636218B1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 03/25/2009 | EP1635641B1 Mitotic kinesin inhibitors |
| 03/25/2009 | EP1380295B1 Photosensitiser and method for production thereof |
| 03/25/2009 | CN101395158A Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 03/25/2009 | CN101394853A Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders |